Use of X-chromosome inactivation pattern and laser microdissection to determine the clonal origin of focal nodular hyperplasia of the liver

Pathology

Volumn 41, Issue 4, 2009, Pages 348-355

  Gong, Li ^a   Li, Yan Hong ^a   Su, Qin ^a,b   Li, Gang ^a   Zhang, Wen Dong ^a   Zhang, Wei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

Author keywords

Clonality analysis; Focal nodular hyperplasia; Laser microdissection; Nodules of altered hepatocytes; X chromosome inactivation

Indexed keywords

ANDROGEN RECEPTOR; GENOMIC DNA; PHOSPHOGLYCERATE KINASE; POLYACRYLAMIDE GEL;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; CHROMOSOME INACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; LIVER HYPERPLASIA; LIVER PARENCHYMA; POLYMERASE CHAIN REACTION; SILVER STAINING; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME; CELL CLONE; DIFFERENTIAL DIAGNOSIS; GENETICS; LASER; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER TUMOR; MICRODISSECTION; MIDDLE AGED; NODULAR HYPERPLASIA; PATHOLOGY; X CHROMOSOME INACTIVATION;

ADENOMA, LIVER CELL; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; LASERS; LIVER NEOPLASMS; MICRODISSECTION; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; X CHROMOSOME INACTIVATION;

EID: 68849089556     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020902885029     Document Type: Article

References (45)

1. Nguyen BN, Flejou JF, Terris B, et al. Focal nodular hyperplasia of the liver: A comprehensive pathologic study of 305 lesions and recognition of a new histologic form. Am J Surg Pathol 1999; 23: 1441-1454
2. Su Q, Liu Q, Wang SF. Clonality analysis technology based on X chromosome genetic polymorphism and application. Zhonghua Bing Li Xue Za Zhi 2002; 31: 162-164
3. Vogelstein B, Fearon ER. Use of restriction fragment length polymorphism to determine the clonal origin of human tumors. Science 1985; 227: 642-644
4. Allen RC, Zoghbi HY, Moseley AB, et al. Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgenreceptor gene correlates with X-chromosome inactivation. Am J Hum Genet 1992; 51: 1229-1239
5. Gartler SM, Riggs AD. Mammalian X-chromosome inactivation. Annu Rev Genet 1983; 17: 155-190
6. Garcia SB, Novelli M, Wright NA. The clonal origin and clonal evolution of epithelial tumors. Int J Exp Pathol 2000; 81: 89-116.
7. Gilliland DG, Blanchard KL, Levy J, et al. Clonality in myeloproliferative disorders: Analysis by means of the polymerase chain reaction. Proc Natl Acad Sci USA 1991; 88: 6848-6852
8. Paradis V, Laurent A, Flejou J, et al. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 1997; 26: 891-895
9. Zhang SH, Cong WM, Wu MC. Focal nodular hyperplasia with concomitant hepatocellular carcinoma: A case report and clonal analysis. J Clin Pathol 2004; 57: 556-559
10. Chen TC, Chou TB, Ng KF, et al. Hepatocellular carcinoma associated with focal nodular hyperplasia. Report of a case with clonal analysis. Virchows Arch 2001; 438: 408-411
11. Ga.ey MJ, Iezzoni JC, Weiss LM. Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 1996; 148: 1089-1096
12. Paradis V, Benzekri A, Dargere D, et al. Telangiectatic focal nodular hyperplasia: A variant of hepatocellular adenoma. Gastroenterol 2004; 126: 1323-1329
13. Ji Y, Zhu XZ, Tan YS, et al. The clinical pathological study of focal nodular hyperplasia. Zhonghua Bing Li Xue Za Zhi 2000; 29: 334-338
14. Anthony PP. Tumors and tumor-like lesions of the liver and biliary tract: Etiology, epidemiology and pathology. In: Macsween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, editors. Pathology of the Liver. London: Churchill Livingstone, 2002; 711-75.
15. Ishak KG, Anthony PR, Sobin LH. De.nition and explanatory notes: Liver. In: Ishak KG, Anthony PR, Sobin LH, editors. Histological Typing of Tumors of the Liver. International Histological Classi.cation of Tumors. Berlin: WHO, 1994; 9-36.
16. Su Q, Bannasch P. Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol Pathol 2003; 31: 126-133
17. Su Q, Benner A, Hofmann WJ, et al. Human hepatic preneoplasia: Phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch 1997; 431: 391-406.
18. Edmondson HA, Steiner PE. Primary carcinoma of the liver: A study of 100 cases among 48900 necropsies. Cancer 1954; 7: 462-503.
19. Gong L, Zhang W, Su Q. Clonal status of .brous dysplasia. Pathology 2008; 40: 392-395
20. Wang SF, Su Q, Zhu SJ, et al. Clonality of multiple uterine leiomyomas. Zhonghua Bing Li Xue Za Zhi 2002; 31: 107-111
21. Watanabe S, Okita K, Harada T, et al. Morphologic studies of the liver cell dysplasia. Cancer 1983; 51: 2197-2205
22. Chu X, Su Q, Gong L, et al. Clonality of nodules of altered hepatocytes in liver with chronic hepatitis B and cirrhosis. World Chin J Digestology 2005; 13: 945-952
23. Kerlin P, Davis GL, McGill DB, et al. Hepatocellular adenoma and focal nodular hyperplasia: Clinical, pathologic, and radiologic features. Gastroenterol 1983; 84: 994-1002.
24. Saul SH, Titelbaum DS, Gansler TS, et al. The .brolamellar variant of hepatocellular carcinoma: Its association with FNH. Cancer 1987; 60: 3049-3055
25. Cherqui D, Rahmouni A, Charlotte F, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: A series of 41 patients with clinical, radiological, and pathological correlation. Hepatology 1995; 22: 1674-1681
26. Wanless IR, Wawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5: 1194-1200
27. Ji Y, Zhu XZ, Tan YS, et al. The clinical pathological study of focal nodular hyperplasia. Zhonghua Bing Li Xue Za Zhi 2000; 29: 334-338
28. Imkie M, Myers SA, Li Y, et al. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: A report of 2 cases. J Reprod Med 2005; 50: 633-637
29. Terada T, Kitani S, Ueda K, et al. Adenomatous hyperplasia of the liver resembling focal nodular hyperplasia in patients with chronic liver disease. Virchows Arch A Pathol Anat Histopathol 1993; 422: 247-252
30. Matsushita M, Hajiro K, Suzaki T, et al. Focal nodular hyperplasia of the liver without central scar. Dig Dis Sci 1995; 40: 2407-2410
31. Nguyen BN, Flejou JF, Terris B, et al. Focal nodular hyperplasia of the liver: A comprehensive pathologic study of 305 lesions and recognition of a new histologic form. Am J Surg Pathol 1999; 23: 1441-1454
32. Saxena R, Humphreys S, Williams R, et al. Nodular hyperplasia surrounding .brolamellar carcinoma: A zone of arterialized liver parenchyma. Histopathology 1994; 25: 275-278
33. Gong Li, Su Qin, Zhang Wei, et al. Live cell-adenoma: A case report with clonality analysis and literature review. World J Gastroenterol 2006; 12: 2125-2129
34. Su Q. Hepatocarcinogenesis associated with viral hepatitis. In: Liu Z-F, Nie Q-H, editors. Diagnosis and Treatment of Viral Hepatitis. Beijing: Renmin Junyi Press, 2001; 221-262
35. Bannasch P. Pathogenesis of hepatocellular carcinoma: Sequential cellular, molecular, and metabolic changes. In: Boyer JL, Ockner RK, editors. Progress in Liver Diseases. Vol.14. Philadelphia: WB Saunders, 1996; 161-197
36. Altmann HW. Hepatic neoformations. Pathol Res Pract 1994; 190: 513-577
37. Balá zs M. Light and electron microscopie examination of a case of primary liver carcinoma in an infant. (German.) Zentralbl Allg Pathol 1976; 120: 3-13.
38. Cain H, Kraus B. Developmental anomalies of the liver and carcinoma of the liver in infants and children. (German.) Dtsch Med Wochenschr 1977; 102: 505-509
39. Fischer G, Hartmann H, Droese M, et al. Histochemical and immunohistochemical detection of putative preneoplastic liver foci in women after long-term use of oral contraceptives. Virchows Arch B Cell Pathol 1986; 50: 321-337
40. Hirota N, Hamazaki M, Williams GM. Resistance to iron accumulation and presence of hepatitisBsurface antigen in preneoplastic and neoplastic lesions in human haemochromatotic livers. Hepatogastroenterology 1982; 29: 49-51.
41. Karhunen PJ, PenttiläA. Preneoplastic lesions of human liver. Hepatogastroenterology 1987; 34: 10-15.
42. Deugnier YD, Charalambous P, Le Quilleuc D, et al. Preneoplastic signi.cance of hepatic ironfree foci in genetic haemochromatosis: A study of 185 patients. Hepatology 1983; 18: 1363-1369
43. Bannasch P, Jahn U-R, Hacker HJ, et al. Focal hepatic glycogenosis: A putative preneoplastic lesion associated with neoplasia and cirrhosis in explanted human livers. Int J Oncol 1997; 10: 261-268
44. Nesbitt MN. Chimeas vs X inactivation mosaics: signi.cance of di.erences in pigment distribution. Dev Biol 197; 38: 202-207
45. Ochiai T, Ueda K, Urata Y. Clonal analysis of hepatocellular carcinoma. Gan To Kagaku Ryoho 1996; 23: 182-188